Page last updated: 2024-12-07

ru 26988

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123987
MeSH IDM0115484

Synonyms (12)

Synonym
ru26988
(8s,9s,10r,11s,13s,14s,17s)-11,17-dihydroxy-10,13-dimethyl-17-prop-1-ynyl-9,11,12,14,15,16-hexahydro-8h-cyclopenta[a]phenanthren-3-one
74915-58-5
ru-26988
androsta-1,4,6-trien-3-one, 11,17-dihydroxy-17-(1-propynyl)-, (11beta,17beta)-
ru 26988
11,17-dihydroxy-17-(1-propynyl)-androsta-1,4,6-trien-3-one,(11beta,17beta)
11,17-dihydroxy-17-pregnane-1,4,6-triene-20-yn-21-methyl-3-one
gtpl3446
Q27088644
cid 123987
AKOS040753855

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Though glucocorticoids have been reported to increase, and progesterone to lower, levels of various milk proteins, clear differences in glucocorticoid dose-response profiles have been previously described."( Steroid receptors, and the generation of closely coupled/biphasic dose-response curves.
Funder, JW; Quirk, SJ, 1988
)
0.27
" The dose-response curve was biphasic, over a 3-300 nM dose range, with maximum at 3-10 nM, followed by a progressive decline toward or to control levels at 300 nM."( Specificity and mechanism of biphasic action of glucocorticoids on alpha-lactalbumin production by rat mammary gland explants.
Fullerton, MJ; Funder, JW; Gannell, JE; Quirk, SJ, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-199039 (90.70)18.7374
1990's4 (9.30)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.40 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (95.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]